NCT00535197View on ClinicalTrials.gov

Autologous Bone Marrow Stem Cells in Ischemic Stroke.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2012

Study Completion Date

December 31, 2012

Conditions
Stroke, AcuteInfarction, Middle Cerebral Artery
Interventions
BIOLOGICAL

Infusion of autologous CD34+ stem cells into middle cerebral artery

intra-arterial infusion into ipsilateral MCA, via trans-femoral approach

Trial Locations (1)

W2 1NY

St Marys Hospital, Paddington

All Listed Sponsors
lead

Imperial College London

OTHER

NCT00535197 - Autologous Bone Marrow Stem Cells in Ischemic Stroke. | Biotech Hunter | Biotech Hunter